Search for: "PAR PHARMACEUTICALS"
Results 161 - 180
of 303
Sort by Relevance
|
Sort by Date
Music broadcasting at the dentist’s and in hotel rooms. CJEU clarifies “communication to the public”
25 Mar 2012, 2:10 am
The CJEU concluded the analysis holding that the exemption to the payment of the equitable remuneration contained in art. 10, par. 1, lett. [read post]
23 Feb 2012, 4:11 pm
On October 14, 2011, Par Pharmaceutical, Inc. [read post]
18 Jan 2012, 10:33 am
Ill, Filed Jan. 11, 2012 Insurance companies, self-insured employers, and union health and welfare plans filed the class action in Illinois Federal Court alleging several RICO violations against Walgreen Co. and Par Pharmaceutical Co. for engaging in a scheme to overcharge for generic versions of Zantac and Prozac. [read post]
16 Nov 2011, 10:00 am
Reddy's Laboratories Ltd., and Par Pharmaceuticals Inc. [read post]
10 Nov 2011, 9:23 pm
Official Liquidator of Esskay Pharmaceuticals Ltd., the SCI (G.S. [read post]
10 Nov 2011, 9:23 pm
Official Liquidator of Esskay Pharmaceuticals Ltd., the SCI (G.S. [read post]
26 Oct 2011, 2:30 am
Par files suit to stop government from expanding its reach (FDA Law Blog) US: Preparing for Mayo v. [read post]
20 Oct 2011, 2:30 pm
Par Pharmaceuticals recently challenged (here and here) FDA’s authority in the off-label promotion arena on First Amendment and Administrative Procedure Act grounds. [read post]
19 Oct 2011, 11:27 am
" MICROSOFT (Matthew McGill, Gibson Dunn): Subject-matter eligibility tests should not involve "pars[ing] the claimed invention into the 'underlying invention' and those aspects that ar [read post]
10 Oct 2011, 10:00 am
In addition, Par may extend the modafinil supply agreement for another year. [read post]
27 Sep 2011, 1:45 pm
Emails and PowerPoints revealing this information were brought to light as a result of a recent suit against Par Pharmaceuticals, the makers of Zantac. [read post]
15 Sep 2011, 5:46 am
Just last month, Florida's attorney general announced an agreement with Par Pharmaceuticals over accusations it inflated prices for medications billed to Medicaid. [read post]
9 Sep 2011, 6:56 am
Par Pharmaceutical Cos., 06-6131, US District Court, Northern District of Illinois (Chicago). [read post]
9 Sep 2011, 6:13 am
We recently reported on the Par Pharmaceuticals lawsuit, and the Pittsburgh Business Times reports that two subsidiaries of Mylan were not pursued by the federal government (a sign that the case is not strong against those two entities). [read post]
8 Sep 2011, 12:59 pm
Par Pharmaceuticals Under Investigation By U.S. [read post]
7 Sep 2011, 4:05 pm
A qui tam complaint against Par Pharmaceuticals was unsealed yesterday in Chicago. [read post]
7 Sep 2011, 4:22 am
Apotex (Patently-O) Glivec (Imatinib mesylate) – India: The Glivec patent saga – its raining recusals (Spicy IP) Glivec (Imatinib mesylate) – India: Supreme Court to hear Novartis challenge to India’s patent law (IP Watch) Lo Loestrin Fe (Norethindrone acetate / Ethinyl estradiol / Ferrous fumarate) – US: Warner Chilcott files patent infringement complaint against Lupin in response to Para IV certification (Patent Docs) Lumigan (Bimatoprost) – US: Allergan files… [read post]
5 Sep 2011, 9:36 pm
Par Pharmaceutical, Inc. et al. v. [read post]
24 Aug 2011, 12:03 pm
In March 2011, a Texas district court entered into a $182 million judgment against two of Par’s co-defendants, Alpharma USPD and Purepac Pharmaceutical Corp., after a unanimous jury verdict. [read post]
16 Aug 2011, 11:35 pm
PTO does not appear to invalidate very many gene patent method claims (Holman’s Biotech IP Blog) US: Machine-or-transformation test after Myriad: Implications to the prosecution of process claims (Patent Law Practice Center) US: Unsuccessful Qui Tam plaintiff asserting false marking claim not immune from costs award: Promote Innovation v Roche Diagnostics (Docket Report) US: FDA releases two medical device draft guidances (FDA Law Blog) US: BIO: Unleashing the promise of biotechnology (pt.4)… [read post]
